A new article in Consumer Reports Best Buy Drugs is reporting that pharmacists filled 43 million prescriptions for sleep drugs in 2005, a number that is up 32% from 2001. The report also notes that direct-to-consumer advertising contributes to increased use of sleep aids.
Consumer Reports finds growth in sleep aid use
A new article in Consumer Reports Best Buy Drugs is reporting that pharmacists filled 43 million prescriptions for sleep drugs in 2005, a number that is up 32% from 2001. The report also notes that direct-to-consumer advertising contributes to increased use of sleep aids. Newer insomnia drugs, such as Ambien and Ambien CR (zolpidem, Sanofi-Aventis), Lunesta (eszopiclone, Sepracor), Sonata (zaleplon, Jones Pharma), and Rozerem (ramelteon, Takeda), are not necessarily better than the older, less expensive drugs such as OTCs or benzodiazepines, according to Consumers Union, publisher of the report. The newer drugs' side effects can range from dizziness and day-after-sleepiness to cognitive impairment and rebound insomnia. The report urges consumers to speak with their healthcare providers to determine their true need for treatment since behavioral therapy alone can improve sleep habits and attitudes toward sleeping and bedtime.
To see more Hot off the Press news articles, click here http://www.drugtopics.com/Hot+off+the+Press.
FDA Expands Tenofovir Alafenamide Indication to Treat HBV in Patients as Young as 6
March 28th 2024Tenofovir alafenamide was originally approved by the FDA in 2016 to treat adults with chronic HBV infection with compensated liver disease and in 2022 to treat pediatric patients aged 12 years and older.